Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Unigene Laboratories (OTC BB:UGNE.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | News | Profile | SEC | Insider | Financials
Recent Events
Aug 31Price hit new 52-week low ($0.23)
Location
110 Little Falls Road
Fairfield, NJ 07004
Phone: (973) 882-0860
Fax: (973) 227-6088
Employees (last reported count): 67
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 16%
·Institutional: 1% (1% of float)
(5 institutions)
·Net Inst. Selling: 5,000  shares (+0.84%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Unigene Laboratories Inc. is a biopharmaceutical company engaged in the research, production and delivery of small proteins (peptides) that have demonstrated or may have potential medical use. The Company has a patented manufacturing technology for producing many peptides cost-effectively. The Company also has patented technology that has been shown to deliver orally medically useful amounts of various peptides into the bloodstream. The Company's primary focus has been on the development of Calcitonin products for the treatment of osteoporosis and other indications. The Company is also engaged in the development of oral and nasal Calcitonin products.
More from Market Guide: Expanded Business Description

Financial Summary
Unigene Laboratories is a biotechnology company that is involved in the research and production of laboratory grade Calcitonin, and the production and marketing of bulk pharmaceutical grade Calcitonin. For the six months ended 6/30/01, revenues fell 74% to $362 thousand. Net loss before accounting change rose 14% to $6.4 million. Results reflect the achievement in developing an oral Calcitonin in the last quarter, partially offset by the absence of J.V. cost.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Jay Levy, 77
Chairman and Treasurer
--  
Warren Levy, Ph.D., 49
Pres, CEO
$174K
Ronald Levy, Ph.D., 52
Exec. VP, Sec., Director
172K
James Gilligan, Ph.D., 49
VP- Product Devel.
156K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:UGNE.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 31-Aug-2001
$0.23 
Recent Price$0.245
52-Week High
on 9-Nov-2000
$3.00 
Beta1.03 
Daily Volume (3-month avg)151.2K
Daily Volume (10-day avg)125.0K
Stock Performance
52-Week Change-89.4%
52-Week Change
relative to S&P500
-85.8%
Share-Related Items
Market Capitalization$11.9M
Shares Outstanding48.4M
Float40.6M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.24 
Earnings (ttm)-$0.26 
Earnings (mrq)-$0.07 
Sales (ttm)$0.06 
Cash (mrq)$0.00 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)4.16 
Income Statements
Sales (ttm)$2.65M
EBITDA (ttm)-$11.3M
Income available to common (ttm)-$11.8M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-123.12%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.03 
Debt/EquityN/A 
Total Cash (mrq)$25.0K
Short Interest
As of 8-Oct-1999
Shares Short0 
Shares Short
(Prior Month)
21.0K
Daily Volume80.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.